This investigation was performed to evaluate the potential with the CPPs with tumor-concentrating on Attributes to deliver a cytotoxic payload to HCC cells. We explored using a CXCR4-concentrating on peptide, T22, fused with cytotoxic peptide PE24, like a novel therapeutic system for CXCR4+ HCC cell